Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Sarcoma, Ewing 1Osteosarcoma 1Osteitis Deformans 1Bone Neoplasms 1

Interventions

Vincristine 2Temozolomide 2Irinotecan 2Doxorubicin 2Cyclophosphamide 2Bone Marrow Transplantation 2robatumumab 1pegfilgrastim 1palbociclib 1lexatumumab 1ganitumab 1disaccharide tripeptide 1delta 24-sterol reductase 1copanlisib 1bempegaldesleukin 1Thiotepa 1Radiosurgery 1Plicamycin 1Peripheral Blood Stem Cell Transplantation 1Nivolumab 1Melphalan 1Magnetic Resonance Spectroscopy 1Interferon-gamma 1Immunotherapy, Adoptive 1INCB059872 1IL32 protein, human 1Granulocyte Colony-Stimulating Factor 1Genistein 1Filgrastim 1FANG vaccine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Sarcoma, Ewing × delta 24-sterol reductase × Clear all
NCT01882231 2017-05-08

Quantitative Imaging Biomarkers of Treatment Response in Osteosarcoma and Ewing Sarcoma

Vanderbilt-Ingram Cancer Center

Phase NA Terminated
6 enrolled
Sarcoma

Bone Neoplasms, Osteitis Deformans, Sarcoma, Ewing, Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡